Literature DB >> 29698801

Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.

Si Liu1, Liming Cheng2, Yang Fu1, Bi-Feng Liu1, Xin Liu3.   

Abstract

Colorectal cancer (CRC) has become one of the most common cancers worldwide and the fifth most prevalent cancer in China with an upward trend in incidence rates. Altered glycosylation significantly affects the structural and functional changes in immunoglobulin G (IgG) and was consequently associated with disease progression. In this study, we explored the association of glycosylation with CRC prognosis through characterizing serum IgG N-glycans derived from individuals consisting of normal, benign colorectal and CRC cohorts in discovery set. Statistical analysis showed nine of IgG N-glycans were differentially expressed in disease groups compared with controls. Additionally, five out of them were still significantly changed in CRC patients at all tumor node metastasis (TNM) stages as compared with controls. Principal component analysis (PCA) indicated obvious differentiation of benign and cancer patients from normal individuals. Further diagnostic performance of receiver operator curve (ROC) analysis demonstrated at least moderately accurate area under the curve (AUC) score with preferable sensitivity and specificity, suggesting these five IgG N-glycans were probably correlated with CRC progression. Significantly, this result has been verified in validation set. Moreover, IgG N-glycosylation analysis suggested that core-fucosylation, sialylation and sialo core-fucosylation were possibly related to the development of CRC. SIGNIFICANCE: In-depth IgG N-glycome profiling of colorectal benign patients, colorectal cancer and normal individuals reveals differentially expression levels of N-glycosylation. Differing from serum comprehensive glycomes, profiling of specific serum glycoprotein contributes to more detailed understanding of biological relevance of glycosylation alterations in disease prognosis. Additionally, the high-throughput technique, MADLI-TOF-MS could absolutely relieve manual stress from sample preparation and accelerate information acquisition as compared to another recent analytical method. Moreover, we introduced a fast and easy data processing of MS exported files based on a software solution, which had the advantage of avoiding time consuming in manually searching and calculating the interesting peaks, and automatically producing the average percentage of each glycan over usual operation with Microsoft Excel. Besides, it may be useful for large-scale study.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CRC; Cancer marker; IgG; Methylamidation; N-glycans; Stage stratification

Mesh:

Substances:

Year:  2018        PMID: 29698801     DOI: 10.1016/j.jprot.2018.04.026

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  8 in total

1.  Adaption of the Aristotle Classifier for Accurately Identifying Highly Similar Bacteria Analyzed by MALDI-TOF MS.

Authors:  Heather Desaire; David Hua
Journal:  Anal Chem       Date:  2019-12-10       Impact factor: 6.986

2.  The Aristotle Classifier: Using the Whole Glycomic Profile To Indicate a Disease State.

Authors:  David Hua; Milani Wijeweera Patabandige; Eden P Go; Heather Desaire
Journal:  Anal Chem       Date:  2019-08-13       Impact factor: 6.986

3.  Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning.

Authors:  Yiqing Pan; Lei Zhang; Rongrong Zhang; Jing Han; Wenjun Qin; Yong Gu; Jichen Sha; Xiaoyan Xu; Yi Feng; Zhipeng Ren; Jiawen Dai; Ben Huang; Shifang Ren; Jianxin Gu
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

4.  Clinically Viable Assay for Monitoring Uromodulin Glycosylation.

Authors:  Milani Wijeweera Patabandige; Eden P Go; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2020-12-10       Impact factor: 3.109

Review 5.  Quantitative clinical glycomics strategies: A guide for selecting the best analysis approach.

Authors:  Milani W Patabandige; Leah D Pfeifer; Hanna T Nguyen; Heather Desaire
Journal:  Mass Spectrom Rev       Date:  2021-02-10       Impact factor: 9.011

6.  Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model.

Authors:  Rubén López-Cortés; Laura Muinelo-Romay; Almudena Fernández-Briera; Emilio Gil-Martín
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

Review 7.  FUT8 and Protein Core Fucosylation in Tumours: From Diagnosis to Treatment.

Authors:  Chengcheng Liao; Jiaxing An; Suqin Yi; Zhangxue Tan; Hui Wang; Hao Li; Xiaoyan Guan; Jianguo Liu; Qian Wang
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

8.  Identification of Whole-Serum Glycobiomarkers for Colorectal Carcinoma Using Reverse-Phase Lectin Microarray.

Authors:  Tomas Bertok; Aniko Bertokova; Eduard Jane; Michal Hires; Juvissan Aguedo; Maria Potocarova; Ludovit Lukac; Alica Vikartovska; Peter Kasak; Lubor Borsig; Jan Tkac
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.